DePuy President’s Deposition Casts Doubt On Company’s Concerns For Safety

Details in the first DePuy hip replacement lawsuit trial shed more light into why the medical device giant failed to recall its defective ASR hip implants sooner. A recently released deposition of DePuy’s President, Andrew Ekdahl, casts even more doubt on the company’s concerns for safety.

Devices Allegedly Not Recalled For Safety Reasons

According to a recent Bloomberg article, Ekdahl said that DePuy’s ASR metal-on-metal hip replacement devices were not recalled for safety reasons, but because they, “did not meet the clinical needs for the product.” Ekdahl’s statements likely shocked many of the 100,000 ASR hip replacement patients worldwide who have either undergone surgery to have the device replaced or live in constant fear of cobalt and chromium poisoning (referred to as metallosis) from the ASR’s metal-on-metal parts rubbing together.

What many find even more disturbing is that Ekdahl didn’t seem to know when his company’s own clinical team was informed about the ASR’s failures and metal toxin issues. When asked if DePuy’s company executives told their clinical teams about what they had learned, he replied, “I believe this was reported to our clinical team…. I just don’t recall who did it. We should have done it. I’m assuming that we did it. I don’t recall.”

It certainly doesn’t give ASR hip injury victims much comfort to know that the company’s own president wasn’t on top of what turned out to be one of the largest – and potentially most dangerous – medical device recalls in recent years.

Stay Tuned For More As First DePuy Hip Trial Continues

The first of 10,000 DePuy ASR hip injury lawsuits has just begun – and has done so with a bang. Stay tuned as more evidence continues to unfold and contact an experienced DePuy hip injury lawyer if you have been injured. You may be entitled to compensation in the form of medical bills, lost income, pain and suffering (both physical and emotional) and more.

Benefactor of Public Justice